O
OS Therapies Incorporated (OSTX)
ASE – Real Time Price. Currency in USD
1.88
+0.08 (4.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.84
-0.04 (-2.13%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
1.88
+0.08 (4.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.84
-0.04 (-2.13%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.05 | 6.05 | 1.0 | |
| Quick ratio | 0.05 | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | -134.95 | -16.91 | 1.0 | |
| Weighted average score | 2.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -805 | -4K | -3K | -363K | -487K |
| Operating Income | -4M | -4M | -7M | -29M | -34M |
| Net Income | -6M | -8M | -9M | -29M | -35M |
| EBITDA | -4M | -4M | -7M | -28M | -33M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 18.42 | 5.0 |
| Next quarter | N/A | 33.33 | 5.5 |
| Current year | N/A | 28.91 | 5.5 |
| Next year | 1133.99 | 78.47 | 10 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 22.76 | 22.86 | -22.33 | 7.8 |
| Y/Y | 999 | -168.17 | -49.99 | -32.58 | 3.3 |
| 3y average | 999 | -87.41 | N/A | -72.31 | 3.3 |
| 5y average | 999 | -34.77 | N/A | -39.96 | 3.3 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $1.3M significantly exceeds cash reserves ($917.6K), raising financial stability concerns
Total current liabilities $17.0M surpass Total current assets $917.6K, signaling liquidity issues
Debt-to-equity ratio (-0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-135.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt